158 related articles for article (PubMed ID: 27388010)
21. Qualitative analysis of enzymatic and chemical depolymerized low molecular weight heparins by UHPLC coupled with electrospray ionization quadrupole time-of-flight-mass spectrometry.
Sadowski R; Gadzała-Kopciuch R; Buszewski B
J Sep Sci; 2020 Aug; 43(15):3036-3044. PubMed ID: 32388896
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.
Alekseeva A; Elli S; Cosentino C; Torri G; Naggi A
Carbohydr Res; 2014 Dec; 400():33-43. PubMed ID: 25457608
[TBL] [Abstract][Full Text] [Related]
23. Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.
Wang Z; Zhang T; Xie S; Liu X; Li H; Linhardt RJ; Chi L
Carbohydr Polym; 2018 Mar; 183():81-90. PubMed ID: 29352895
[TBL] [Abstract][Full Text] [Related]
24. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
25. Structural modification induced in heparin by a Fenton-type depolymerization process.
Vismara E; Pierini M; Guglieri S; Liverani L; Mascellani G; Torri G
Semin Thromb Hemost; 2007 Jul; 33(5):466-77. PubMed ID: 17629843
[TBL] [Abstract][Full Text] [Related]
26. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
27. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
[TBL] [Abstract][Full Text] [Related]
28. Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple time-of-flight mass spectrometry.
Ouyang Y; Zeng Y; Rong Y; Song Y; Shi L; Chen B; Yang X; Xu N; Linhardt RJ; Zhang Z
Anal Chem; 2015 Sep; 87(17):8957-63. PubMed ID: 26222954
[TBL] [Abstract][Full Text] [Related]
29. [Advances in heparin structural analysis by chromatography technologies].
Ouyang Y; Yi L; Qiu L; Zhang Z
Se Pu; 2023 Feb; 41(2):107-121. PubMed ID: 36725707
[TBL] [Abstract][Full Text] [Related]
30. Specific Non-Reducing Ends in Heparins from Different Animal Origins: Building Blocks Analysis Using Reductive Amination Tagging by Sulfanilic Acid.
Mourier PAJ
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256116
[TBL] [Abstract][Full Text] [Related]
31. Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin.
Gupta R; Ponnusamy MP
Expert Rev Proteomics; 2018 Jun; 15(6):503-513. PubMed ID: 29782806
[TBL] [Abstract][Full Text] [Related]
32. Production and chemical processing of low molecular weight heparins.
Linhardt RJ; Gunay NS
Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
[TBL] [Abstract][Full Text] [Related]
33. Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.
Dietrich CP; Shinjo SK; Moraes FA; Castro RA; Mendes A; Gouvea TC; Nader HB
Semin Thromb Hemost; 1999; 25 Suppl 3():43-50. PubMed ID: 10549715
[TBL] [Abstract][Full Text] [Related]
34. Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.
Li L; Zhang F; Zaia J; Linhardt RJ
Anal Chem; 2012 Oct; 84(20):8822-9. PubMed ID: 22985071
[TBL] [Abstract][Full Text] [Related]
35. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
36. MsPHep: An online application for low molecular weight heparin rapid characterization based on liquid chromatography-tandem mass spectrometry.
Xie S; Bu C; LaCava J; Chi L
J Chromatogr A; 2023 Aug; 1705():464179. PubMed ID: 37419018
[TBL] [Abstract][Full Text] [Related]
37. Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins.
Houiste C; Auguste C; Macrez C; Dereux S; Derouet A; Anger P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):50-8. PubMed ID: 18805847
[TBL] [Abstract][Full Text] [Related]
38. Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR.
Liu X; St Ange K; Wang X; Lin L; Zhang F; Chi L; Linhardt RJ
Anal Chim Acta; 2017 Apr; 961():91-99. PubMed ID: 28224913
[TBL] [Abstract][Full Text] [Related]
39. Feasibility study of heparin mass calibrator as a GPC calibrator for heparins and low molecular weight heparins.
Ahsan A; Jeske W; Mardiguian J; Fareed J
J Pharm Sci; 1994 Feb; 83(2):197-201. PubMed ID: 8169788
[TBL] [Abstract][Full Text] [Related]
40. Quality control, safety assessment and preparation approaches of low molecular weight heparin.
Yu Y; Song Y; Zhao Y; Wang N; Wei B; Linhardt RJ; Dordick JS; Zhang F; Wang H
Carbohydr Polym; 2024 Sep; 339():122216. PubMed ID: 38823901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
